Cannabis Law Report

APRIL 12, 2019

Being of European descent it is a privilege to be updating Europe on such an exciting topic. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

MARCH 9, 2022

While there have been a lot of advocacy efforts to change their national implementation, a coalition of drug policy reform named International Therapeutic Psilocybin Rescheduling Initiative ( ITPRI ) has been set up to push for greater change at the UN level.

Advocacy 52

Advocacy Research and Development Policy Topical 52

Cannabis Law Report

DECEMBER 5, 2021

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines. CBE write. cannabis-initiative-2-dec-2021-INCB-contribution.

Research and Development 118

Research and Development Medicine Access Advocacy 118

Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. CB4 Derma Topical. patients must register at Opticann.ca ’s advocacy. In conjunction with the partnership, C.A.R.P, members through C.A.R.P. CB4 Relief Deep Rub Gel. CB4 Clear Face Gel. Most C.A.R.P.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

NORML

MARCH 3, 2020

Medical marijuana patients can register with the state to obtain a home cultivation permit, which allows the state to enter a patient’s house at any time for inspection. Medical patients are restricted to 4 plants total, per household.

Programs 188

Programs Legislation Cultivation Legalization 188

MassRoots

NOVEMBER 19, 2018

One week after Utah voters approved a medical marijuana ballot initiative, a lawyer representing patients and advocates has formally notified the Mormon church to preserve records ahead of a potential lawsuit concerning its alleged attempts to undermine the measure. As you know, I’m an active member of The Church, and that will remain true.

Marijuana 49

Marijuana Legislation Advocacy Patients 49

Veriheal

JULY 27, 2020

NORML is a cannabis advocacy group that fights for the rights of cannabis users. FOCUS is an organization concerned with the development of standards of quality within the cannabis industry—a tough topic since there is currently no federal oversight. NORML Gives Back by Advocating for Legalization.

Research and Development 62

Research and Development Chronic Pain Education Advocacy 62

Cannabis Law Report

NOVEMBER 29, 2021

CRIC represents the highest standards, ethics and best practices; provides effective promotion and advocacy of the industry; serves as a source of information and thought leadership; and is a forum for collective industry action. Medical Cannabis Canada* , Max Monahan-Ellison (max@patientaccess.ca).

Research and Development 52

Research and Development Topical Programs Business 52

Cannabis Law Report

NOVEMBER 29, 2021

Since Trulieve was founded, our patients, customers and employees have been at the heart of everything we do. Key takeaways from the ESG report include: Conducted our inaugural materiality assessment with an ESG consultant to identify and prioritize key non-financial topics for our business and stakeholders.

Topical 52

Topical Business Cannabis Access 52

NORML

JUNE 5, 2019

All of these FREE events will focus on rules and regulations of Amendment 2, now Article XIV, for patients and caregivers. These events will have a special topic each month and everyone will have time for Q&A. Donate today to support our efforts!

Education 37

Education Events Patients Programs 37

CannaTech

NOVEMBER 10, 2019

I spoke to Namibian cannabis activist Angela Prusa about her country’s efforts to suppress cannabis advocacy. We have more and more hemp products coming from South Africa or from Europe that are on the shelves, but our regulations only permit 0.001% of THC and only for topical use. Angela, thank you so much for speaking with us.

History 40

History Research and Development Cannabis Education 40

CannaTech

NOVEMBER 19, 2019

I spoke to activist Angela Prusa about cannabis in Namibia and recent government efforts to suppress cannabis advocacy. We have more and more hemp products coming from South Africa or from Europe that are on the shelves, but our regulations only permit 0.001% of THC and only for topical use.

History 80

History Research and Development Cannabis Education 80

CannaTech

NOVEMBER 19, 2019

I spoke to activist Angela Prusa about cannabis in Namibia and recent government efforts to suppress cannabis advocacy. We have more and more hemp products coming from South Africa or from Europe that are on the shelves, but our regulations only permit 0.001% of THC and only for topical use.

History 76

History Research and Development Cannabis Education 76

The Cannigma

DECEMBER 19, 2021

Medical cannabis use for children can be a sensitive topic for even the most vocal cannabis activists. Approaching the topic from a medical and humane perspective, however, can help patients in need of less harmful pain and symptom relief, or provide a better lifestyle.

Treatment 135

Treatment Patients Dispensary Microdosing 135

The Cannigma

DECEMBER 12, 2022

Using integration or psychotherapy along with these medicines allows patients to incorporate the positive effects permanently. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. The after-glow is essentially the opposite of a hangover.

History 119

History Microdosing Research and Development Clinical Trials 119

The Cannigma

APRIL 7, 2022

I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. All you have to do is you just have to be patient. It’s not going to last forever, but it will last awhile. MB: No, that’s slow.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

Cannabis Law Report

JANUARY 15, 2019

We have previously written extensively on this topic. A dispensary case is pending before the Tax Court – Patients Mutual Assistance Collective Corporation d.b.a. 3d 1217 (9th Cir. 1999) (Reliance on accountant in treating option sale as capital gain instead of ordinary income held reasonable); IRM 20.1.1.3.2.4.3 (8-20-98).

Business 58

Business Dispensary Cannabis Compliance 58

Veriheal

AUGUST 31, 2021

She provides clear strategies for teaching healthcare professionals how to improve their proficiency and cultural competency for caring for medical marijuana patients. Such a flow of information would empower medical marijuana patients to review the chemical contents, benefits and side effects, and allergy information for products.

Research and Development 108

Research and Development Supply Chain Programs Education 108

SpeedWeed

MAY 27, 2021

She started her cannabis journey nearly 20 years ago as a medical marijuana patient in Los Angeles, and swiftly transitioned into advocacy and activism, helping the first dispensaries land ads in LA Weekly. Cannabinoids are for everyone, from the most skittish, casual tokers, to the day-to-night dabbers, to the topical moms.

Strains 52

Strains History Dispensary Cannabis 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Joint Blog

JUNE 15, 2021

The legalization of marijuana seeds at the federal level is a hot topic. It is due to the increased support on the state government level and a strong need for reforms from social justice advocacy groups. So, be patient and enjoy the revolutionary changes that are yet to come because, trust us, they will! Will the U.S.

Legalization 52

Legalization Decriminalization Recreational State Laws 52

Cannabis Law Report

JUNE 25, 2021

Tribble founded Marijuana Matters (M2), a cannabis education and advocacy incubator, and is also the founder of the Marijuana Policy Trust (MPT), a think tank providing expertise toward building an inclusive and diverse cannabis industry. Prior to joining Curaleaf (NASDAQ: CURLF), Ms. Joe Dolce- Brave New Weed, Medical Cannabis Mentor.

Research and Development 99

Research and Development Media Pets Medicine 99

Cannabis Law Report

FEBRUARY 2, 2020

On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. .

Hemp 69

Hemp Research and Development Packaging Cultivation 69

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

The Cannigma

DECEMBER 8, 2021

To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today! And I think it’s an interesting question that I get it a lot and I’ve heard it asked of other patients as well, and I think it’s kind of a question that we all take for granted is like the one to ask.

Access 81

Access Policy Patients Cannabis 81

The Cannigma

FEBRUARY 16, 2022

I love the fact that we’re really starting to lean into this more because I think it’s a topic that deserves attention. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. EG: All right, so that’s going to be straight up to the interview. CP: I’m great.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

NORML

APRIL 26, 2019

Among the changes are: allowing physicians assistants to recommend medical cannabis to their patients, adding several new qualifying conditions, and authorizing cancer patients to possess greater quantities of cannabis than typically allowed. AL resident? Click here to email your lawmakers in support of decriminalization. AL resident?

Legislation 143

Legislation Compliance Compliance Hemp 143

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

MAY 10, 2019

The industry is growing: More than $2 billion in annual revenue is expected in the next five years, with patients over 50 years old driving the boom. Despite strong advocacy for medical cannabis from her Cabinet colleagues, however, Moody says none have broached the banking topic with her. Source: [link].

Banking 58

Banking Advocacy Legislation Agriculture 58

SpeedWeed

APRIL 1, 2021

Nikki Fried wasn’t part of the legislature during the initial passage of medical cannabis in 2016 but did participate in the advocacy movement while working as a government consultant. While some are coming around on the topic, that hasn’t been the case for previous Governor Rick Scott or the current leader of the state, Ron DeSantis.

Agriculture 52

Agriculture Policy THC Advocacy 52

Cannabis Law Report

JUNE 4, 2021

Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Healing Advocacy Fund.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 16, 2021

says, Glen Caroline Head of Advocacy WAB Strategic and ACCM Outreach Committee Co-Chair “Their experience and knowledge provide a critical asset for our work with legislators. national advocacy program.”. Several members of the Council have been working with the ACCM Alliance on multiple legislative and advocacy issues.

Legislation 98

Legislation Medicine Advocacy Research and Development 98

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 207

Marijuana Legalization Programs Oil 207